WashU Medicine physicians at Siteman Cancer Center are recognized nationally for their expertise in leading-edge breast cancer therapies. Nearly 50 specialists in surgery, breast reconstruction, medical oncology and radiation oncology, radiology and pathology are part of the Breast Cancer Program at Siteman, providing personalized treatment plans for patients. Advanced genetic testing, including tests developed by […]
A retrospective systemic literature review showed that increased lines of therapy led to decreased HRQOL in patients with relapsed/refractory myeloma.
Acha-Sagredo et al. stratify colorectal cancers using features of an immune-reactive tumor microenvironment. This microenvironment, locally abundant in cytotoxic lymphocytes and antigen-presenting macrophages, facilitates immunotherapy response…
Please join us at the SABR Canada Conference taking place on Thursday June 5 & Friday June 6, 2025, at the Delta by Marriott Grand…
In this episode of Lung Cancer Considered, host Dr. Stephen Liu moderates a Virtual Tumor Board case involving drug resistance in EGFR mutant NSCLC. This…
Marwan G. Fakih, MD, discusses the FDA approval of sotorasib plus panitumumab in KRAS G12C–mutated metastatic colorectal cancer.
Blood Advances | 9 | 3 | February 2025
High dose rate (HDR) brachytherapy is an essential component in the curative treatment for many gynecologic (gyn) cancers, including cervical cancer, uterine cancer, vaginal cancer,…
My entire life I was told to respectfully question anything and everything, because questions equal answers, which provide understanding and thereby comfort—even with the uncomfortable.…
In a comparison study, benefits of nurse-led preoperative counseling and follow-up care was significantly greater compared with surgeon-led or no counseling models.
Serial CTRS, an AI-powered tool, has been granted FDA breakthrough device designation for classifying patients with NSCLC.
